Advertisement

Cefazolin Injection

[17 April 2015]

Products Affected - Description

Cefazolin injection, Fresenius Kabi
10 gram, 1 count (NDC 63323-0238-61)
20 gram, 1 count (NDC 63323-0446-66)

Cefazolin injection, Apotex
1 gram, 25 count (NDC 60505-0749-05)
10 gram, 1 count (NDC 60505-0769-00)
 
Cefazolin injection, BBraun
1 gram/50 mL premix, 1 count (NDC 00264-3103-11)
2 gram/50 mL premix, 1 count (NDC 00264-3105-11)
 
Cefazolin injection, Hospira
10 gram, 10 count (NDC 00409-0806-01)
 
Cefazolin injection, Sagent
1 gram, 25 count (NDC 25021-0101-10)
10 gram, 1 count (NDC 25021-0102-99) 
 
Cefazolin injection, West-Ward
10 gram, 10 count (NDC 00143-9983-03)
 
Cefazolin injection, WG Critical Care
500 mg, 25 count (NDC 44567-0706-25)
20 gram, 10 count (NDC 44567-0709-10)

Reason for the Shortage

  • Fresenius Kabi, BBraun, West-Ward, and WG Critical Care have cefazolin on shortage due to increased demand.
  • WG Critical Care is not producing cefazolin 20 gram to focus on other strengths.
  • Apotex and Sandoz have cefazolin on shortage due to manufacturing delays.
  • Hospira has cefazolin on shortage due to manufacturing delays.
  • Sagent has cefazolin on shortage due to manufacturing delays.

Available Products

Cefazolin injection, Baxter
1 gram/ 50 mL premix, 24 count (NDC 00338-3503-41)
 
Cefazolin injection, Fresenius Kabi
500 mg, 1 count (NDC 63323-0236-10)
1 gram, 25 count (NDC 63323-0237-10)
 
Cefazolin injection, Hospira
1 gram, 25 count (NDC 00409-0805-01)
1 gram, Add-Vantage vial, 25 count (NDC 00409-2585-01)
 
Cefazolin injection, Sagent
500 mg, 25 count (NDC 25021-0100-10)
 
Cefazolin injection, Samson Medical Technologies
100 gram SmartPak bulk package (NDC 66288-1100-01)
300 gram SmartPak bulk package (NDC 66288-1300-01)
 
Cefazolin injection, Sandoz
500 mg, 10 count (NDC 00781-3450-95)
1 gram, 25 count, (NDC 00781-3451-96)
10 gram, 10 count (NDC 00781-3452-95)

Cefazolin injection, West-Ward
500 mg, 25 count (NDC 00143-9923-90)
1 gram, 25 count (NDC 00143-9924-90)
 
Cefazolin injection, WG Critical Care
1 gram, 25 count (NDC 44567-0707-25)
10 gram, 10 count (NDC 44567-0708-10)

Estimated Resupply Dates

  • Apotex has cefazolin 1 gram and 10 gram vials on allocation.
  • Fresenius Kabi has cefazolin 10 gram vials on back order and the company cannot estimate a release date. Cefazolin 20 gram vials are on back order and the company estimates a release date of 2nd quarter 2015.
  • BBraun has cefazolin 1 gram/50 mL and 2 gram/50 mL premixes on allocation for contracted customers.
  • Hospira has cefazolin 10 gram vials on allocation.
  • Sagent has cefazolin 1 gram and 10 gram vials on back order and the company estimates a release date of April 2015 for the 1 gram vials and May 2015 for the 10 gram vials.
  • West-Ward has cefazolin 10 gram vials on allocation.
  • WG Critical Care has cefazolin 500 mg vials on back order and the company estimates a release date of late-April 2015. Check wholesalers for inventory.

Related Shortages

Updated

April 2 and 17, March 10, February 5 and 20, January 9 and 20, 2015; December 5, 12, and 22, November 6, 11, 20, and 21, October 1 and 16, September 4, 18, and 26, August 21, July 18, June 13 and 26, May 8, 12, and 28, April 2, 15, and 30, March 5, 18, and 25, February 10 and 19, January 6, 21, 24, and 29, 2014; December 3 and 19, November 13, October 10, 21, and 30, September 3 and 23, August 1, 13, and 27, July 3 and 18, June 6, May 6 and 30, April 1 and 12, March 7 and 29, February 5 and 12, January 10 and 23, 2013, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement